JPS563000A - Water-soluble cholesterol derivative - Google Patents

Water-soluble cholesterol derivative

Info

Publication number
JPS563000A
JPS563000A JP7676779A JP7676779A JPS563000A JP S563000 A JPS563000 A JP S563000A JP 7676779 A JP7676779 A JP 7676779A JP 7676779 A JP7676779 A JP 7676779A JP S563000 A JPS563000 A JP S563000A
Authority
JP
Japan
Prior art keywords
formula
dibasic acid
organic dibasic
half ester
acid half
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7676779A
Other languages
English (en)
Inventor
Yoshio Arakawa
Atsukore Takanabe
Yatsuhiro Kamimura
Satoru Funakoshi
Daisuke Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Priority to JP7676779A priority Critical patent/JPS563000A/ja
Priority to CA000352892A priority patent/CA1154755A/en
Priority to SE8004125A priority patent/SE445833B/sv
Priority to US06/156,091 priority patent/US4304726A/en
Priority to GB8018483A priority patent/GB2053924B/en
Priority to DE3022788A priority patent/DE3022788C2/de
Priority to FR8013618A priority patent/FR2459248A1/fr
Publication of JPS563000A publication Critical patent/JPS563000A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
JP7676779A 1979-06-20 1979-06-20 Water-soluble cholesterol derivative Pending JPS563000A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP7676779A JPS563000A (en) 1979-06-20 1979-06-20 Water-soluble cholesterol derivative
CA000352892A CA1154755A (en) 1979-06-20 1980-05-28 Cholesterol derivatives
SE8004125A SE445833B (sv) 1979-06-20 1980-06-03 Halvester av organisk tvabasisk syra och 7-ketokolesterol eller 7-hydroxikolesterol
US06/156,091 US4304726A (en) 1979-06-20 1980-06-03 Process for the preparation of cholesterol derivatives
GB8018483A GB2053924B (en) 1979-06-20 1980-06-05 Immunosuppressive 3-hemiesters of7-oxygenated cholesterol
DE3022788A DE3022788C2 (de) 1979-06-20 1980-06-18 7-Ketocholesterin- und 7-Hydroxycholesterin-berstein- bzw. -phthal-säure-halbester und ihre Salze und ihre Verwendung als Immunsuppressiva und Antiphlogistika
FR8013618A FR2459248A1 (fr) 1979-06-20 1980-06-19 Hemi-esters du cholesterol utilisables en medecine et leur procede de fabrication

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7676779A JPS563000A (en) 1979-06-20 1979-06-20 Water-soluble cholesterol derivative

Publications (1)

Publication Number Publication Date
JPS563000A true JPS563000A (en) 1981-01-13

Family

ID=13614739

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7676779A Pending JPS563000A (en) 1979-06-20 1979-06-20 Water-soluble cholesterol derivative

Country Status (7)

Country Link
US (1) US4304726A (ja)
JP (1) JPS563000A (ja)
CA (1) CA1154755A (ja)
DE (1) DE3022788C2 (ja)
FR (1) FR2459248A1 (ja)
GB (1) GB2053924B (ja)
SE (1) SE445833B (ja)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60258198A (ja) * 1984-06-04 1985-12-20 Amano Pharmaceut Co Ltd トリテルペンアルコ−ル有機酸エステル及びその製造法
JPWO2003022866A1 (ja) * 2001-09-07 2004-12-24 栄次 松浦 β２−グリコプロテインＩに対するリガンド及びその用途
JP2012516900A (ja) * 2009-02-05 2012-07-26 トーカイ ファーマシューティカルズ，インク． ステロイド性ｃｙｐ１７阻害剤／抗アンドロゲン剤の新しいプロドラッグ
US9808472B2 (en) 2013-08-12 2017-11-07 Tokai Pharmaceuticals, Inc. Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
US9884067B2 (en) 2013-03-14 2018-02-06 University Of Maryland, Baltimore Androgen receptor down-regulating agents and uses thereof
US10098896B2 (en) 2005-03-02 2018-10-16 University Of Maryland Baltimore C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens, in vitro biological activities, pharmacokinetics and antitumor activity

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442037A (en) * 1981-03-13 1984-04-10 Yoshio Arakawa Water-soluble cholesterol derivative
DE3803757A1 (de) * 1988-02-08 1989-08-17 Boehringer Mannheim Gmbh Cholesterin-esterase-farbsubstrat
US5496806A (en) * 1990-01-23 1996-03-05 R. Erich Klemke Glycoside compounds and production and use thereof
FI974648A (fi) 1997-09-09 1999-05-06 Raisio Benecol Oy Hydroksihappo-, maitohappo- ja hydroksialkanoaattiesterit ja niiden käyttö
IL146223A0 (en) 1999-04-30 2002-07-25 Arch Dev Corp Steroid derivatives
EP1385868A4 (en) * 2001-02-08 2004-12-08 Univ Chicago STEROID DERIVATIVES
US7078396B2 (en) * 2001-05-03 2006-07-18 Arch Development Corporation Method of treating disorder related to high cholesterol concentration
US20070197484A1 (en) * 2001-05-03 2007-08-23 Ching Song Method of treating disorder related to high cholesterol concentration
DK1392713T3 (da) * 2001-05-03 2008-02-18 Univ Chicago Lever-X-receptoragonister
CA2482195A1 (en) * 2002-04-12 2003-10-23 The University Of Chicago Farnesoid x-activated receptor agonists
US20070032464A1 (en) * 2004-10-08 2007-02-08 Shutsung Liao Methods of treating cancers
US8829213B2 (en) * 2009-07-29 2014-09-09 The University Of Chicago Liver X receptor agonists
EP2522350B1 (de) * 2011-05-12 2013-07-31 Immunopharm AG Verwendung der Wirkstoffkombination aus einem 1-Diethylaminoethyl-3-Chinoxalin-2-on Derivat und einem Oxysterol zur Durchbrechung von Resistenzen bei der Behandlung von Krebs und zur Erhöhung der Immunleistungsfähigkeit bei Krebs, bakteriellen und viralen Erkrankungen, Autoimmunerkrankungen, erhöhter Stress- und Umweltbelastung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1224738B (de) * 1960-12-29 1966-09-15 Takeda Chemical Industries Ltd Verfahren zur Herstellung von Cholestan-3, 5, 6-triol-3-estern oder -3, 6-diestern soowie von deren Salzen
GB1553540A (en) * 1977-02-23 1979-09-26 Green Cross Corp Medicaments containing cholesterol derivatives
US4202891A (en) * 1977-05-16 1980-05-13 Kandutsch Andrew A 15-Oxygenated sterol compounds and the use of such compounds to inhibit the biosynthesis of sterols
US4189400A (en) * 1977-08-17 1980-02-19 Bonderman Dean P Compound useful in cholesterol assay procedures
US4225525A (en) * 1979-02-08 1980-09-30 Hoffmann-La Roche Inc. Vitamin D3 metabolite derivatives

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60258198A (ja) * 1984-06-04 1985-12-20 Amano Pharmaceut Co Ltd トリテルペンアルコ−ル有機酸エステル及びその製造法
JPH0140040B2 (ja) * 1984-06-04 1989-08-24 Amano Pharma Co Ltd
JPWO2003022866A1 (ja) * 2001-09-07 2004-12-24 栄次 松浦 β２−グリコプロテインＩに対するリガンド及びその用途
US10098896B2 (en) 2005-03-02 2018-10-16 University Of Maryland Baltimore C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens, in vitro biological activities, pharmacokinetics and antitumor activity
JP2012516900A (ja) * 2009-02-05 2012-07-26 トーカイ ファーマシューティカルズ，インク． ステロイド性ｃｙｐ１７阻害剤／抗アンドロゲン剤の新しいプロドラッグ
US9884067B2 (en) 2013-03-14 2018-02-06 University Of Maryland, Baltimore Androgen receptor down-regulating agents and uses thereof
US9808472B2 (en) 2013-08-12 2017-11-07 Tokai Pharmaceuticals, Inc. Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies

Also Published As

Publication number Publication date
US4304726A (en) 1981-12-08
GB2053924A (en) 1981-02-11
SE445833B (sv) 1986-07-21
DE3022788A1 (de) 1981-01-08
GB2053924B (en) 1983-04-27
FR2459248B1 (ja) 1983-10-28
CA1154755A (en) 1983-10-04
DE3022788C2 (de) 1982-08-12
SE8004125L (sv) 1980-12-21
FR2459248A1 (fr) 1981-01-09

Similar Documents

Publication Publication Date Title
JPS563000A (en) Water-soluble cholesterol derivative
ES477181A1 (es) Procedimiento para la preparacion de complejos de inclusion de ciclodextrina.
ES485650A1 (es) Procedimiento para la preparacion de 1,2,3-tiadiazol-5-il- ureas
GB1457077A (en) Preparation of 25-hydroxycholesterol and esters thereof
GB1317194A (en) 21,21-dichloro-steroids
JPS527484A (en) Process for preparing cholesterol oxidase
JPS5256193A (en) Process for copolyesterpolyol
JPS54151985A (en) Preparation of aminocarbostyril derivative
JPS5371033A (en) Preparation of 4-alkoxycarbonyl-3,5-dimethylphthalic acid anhydride
JPS5535007A (en) Organic germanium hydride compound
JPS57131738A (en) Novel cyclohexanecarboxylic acid derivative
GB2019250A (en) Preparation of metal components for treatment
JPS5535017A (en) Beta-nitrostyrene derivative
JPS5770900A (en) 5alpha-ergosta-6-one derivative
JPS5373519A (en) Preparation of reactive monomer
JPS5479247A (en) Para-substituted phenylacetic acid derivative and its preparation
JPS5436274A (en) Preparation of propiophenone derivative
JPS5257127A (en) Process for hexyne-3-ol-1
JPS53108983A (en) Preparation of 5-fluorouracil
JPS5543027A (en) 2-pyridyl-1-phthalazone derivative
Salak Properties of Powder Iron Produced by Means of Reduction of Ferric Oxide Recovered from Spent Baths After Hydrochloric Acid Pickling of Steels Using the Lurgi Process
JPS5218284A (en) Multi-shaft piercing machine for h shape section steel bar
GB1490476A (en) 6-aminomethylated-3-oxygenated cholest-5-enes
JPS51141895A (en) Process for preparing 1,4-diaza-bicyclo(2,2,2)octane
JPS527950A (en) Preparation of ursodeoxycholic acid